News
Access our latest news on new services, features, and partnerships.
Don't miss our latest news, follow us on LinkedIn.
-
QOL Technologies Ltd. partners with Mapi Research Trust for the management of their COAs
Starting in November 2024, all requests for use shall be sent directly to Mapi Research Trust via the ePROVIDE platform.
-
Announcing Outcome Measures: A Collection of ICON Services to Advance Patient-Centered Clinical Trials
Mapi Research Trust’s sponsor ICON launched a new capability: Outcome Measures, an end to end service that supports sponsors in the identification, selection and implementation of measures that matter to patients.
-
The South London and Maudsley NHS Foundation Trust partners with Mapi Research Trust
The South London and Maudsley NHS Foundation Trust entrusts Mapi Research Trust with the exclusive distribution and licensing of the SDS-Gossop and the SOWS-Gossop.
-
Rare Disease Day: raising awareness and improving patients’ quality of life
Learn about initiatives to improve quality of life of people with rare diseases and to make their voices heard in clinical research. -
New functionalities in ePROVIDE
The ePROVIDE platform deploys new features and improves the display of key information. -
The KOOS, HOOS and FAOS now distributed by Mapi Research Trust, on behalf of Professor Roos
Mapi Research Trust has recently enriched its catalogue with 3 new COAS, developed and owned by Professor Ewa Roos: the KOOS, HOOS and FAOS. -
Mapi Research Trust partners with Springer Nature.
Mapi Research Trust announces a new partnership with Springer Nature to support the distribution of Clinical Outcome Assessments (COAs). -
Five rheumatology and hematology COAs newly available through Mapi Research Trust
Mapi Research Trust’s catalog of COAs now includes 5 new questionnaires available for streamlined licensing through the ePROVIDE platform. -
MSD COA website
Merck Sharp & Dohme LLC, Rahway, NJ, USA (MSD) collaborates with Mapi Research Trust to launch MSD’s COA Website. -
Observia partners with Mapi Research Trust for the distribution of the SPUR Adherence Profiling Tool
Mapi Research Trust: exclusive partner of Observia for the licensing/distribution of SPUR (context of clinical research not located in Greater China).
